Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jason Raleigh Nunn currently holds 1,173,395 shares of HYPERION THERAPEUTICS INC (HPTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jason Raleigh Nunn has been a net buyer of HPTX stock. They have purchased $16.2M and sold $0 worth of shares.
Jason Raleigh Nunn's most recent insider trade was on Oct 9, 2025, when they purchased 63,158 shares at $19.00 per share.
Jason Raleigh Nunn serves as Executive at HYPERION THERAPEUTICS INC (HPTX). They have executed 19 insider transactions totaling $16.2M over their tenure at the company.
Jason Raleigh Nunn holds the position of Executive at HYPERION THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Jason Raleigh Nunn has shown a buying trading pattern, with $16.2M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Jason Raleigh Nunn was on Sep 16, 2024, when they purchased $7.5M worth of ZBIO shares. This transaction involved 441,176 shares at $17.00 per share.
Jason Raleigh Nunn currently owns 1,173,395 shares of HYPERION THERAPEUTICS INC (HPTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jason Raleigh Nunn's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jason Raleigh Nunn has 19 Form 4 filings on record as an insider at HYPERION THERAPEUTICS INC.
Set alerts for Jason Raleigh Nunn and 40,000+ other insiders.